Synthetic-polymer-assisted antisense oligonucleotide delivery: targeted approaches for precision disease treatment

• Ana Cubillo Alvarez,
• Dylan Maguire and
• Ruairí P. Brannigan

Beilstein J. Nanotechnol. 2025, 16, 435–463, doi:10.3762/bjnano.16.34

• reduce cytotoxicity. The study revealed that the PEGylated PLR–CS conjugate (PEG-CS-PLR) formed stable complexes with siRNA and significantly improved cellular uptake compared to CS and PLR alone. Notably, PEG-CS-PLR demonstrated enhanced serum stability and reduced hemolysis, which are critical for in

A nanocarrier containing carboxylic and histamine groups with dual action: acetylcholine hydrolysis and antidote atropine delivery

• Elina E. Mansurova,
• Andrey A. Maslennikov,
• Anna P. Lyubina,
• Alexandra D. Voloshina,
• Irek R. Nizameev,
• Marsil K. Kadirov,
• Anzhela A. Mikhailova,
• Polina V. Mikshina,
• Albina Y. Ziganshina and
• Igor S. Antipin

Beilstein J. Nanotechnol. 2025, 16, 11–24, doi:10.3762/bjnano.16.2

• concentration range (13–1650 μM) and did not cause hemolysis even at the highest concentration of 825 μM (Table 2 and Supporting Information File 1, Figure S4). Hist-RA at 220 μM led to nearly 100% hemolysis (Supporting Information File 1, Figure S4), while at concentrations of 110 and 55 μM, agglutination was

• observed (Figure 4). With further dilution, no erythrocyte effects were noted, as confirmed by bright-field microscopy (Figure 4). The nanocarrier p(Hist-CA) induced hemolysis (27.1%) and agglutination solely at the highest concentration (Figure 3 and Supporting Information File 1, Figure S4). Degradation

• was approved by the ethical committee of the FRC Kazan Scientific Center of RAS according to Russian national ethical guidelines (protocol No. 9–2013). No organs/tissues were procured from prisoners. Hemolysis of human red blood cells The hemolytic activity of Hist-RA, CA-RA, and p(Hist-CA) were

Dual-functionalized architecture enables stable and tumor cell-specific SiO₂NPs in complex biological fluids

• Iris Renata Sousa Ribeiro,
• Raquel Frenedoso da Silva,
• Romênia Ramos Domingues,
• Adriana Franco Paes Leme and
• Mateus Borba Cardoso

Beilstein J. Nanotechnol. 2024, 15, 1238–1252, doi:10.3762/bjnano.15.100

• exhibit heightened efficacy and reduced toxicity for medical purposes. Keywords: colloidal stability; complex media; functionalized nanoparticles; hemolysis; targeting tumor; Introduction In recent years, there has been a growing search for developing high-efficiency nanomedicines for cancer treatment

• , and analyzed with a spectrophotometer (EnSpire 2300, Perkin Elmer) setting the excitation wavelength at 560 nm and the emission wavelength at 590 nm. Analyses were performed in triplicate. Hemolysis assay in human concentrated red blood cell plastic bag and murine blood Transfusion service human

• to cause hemolysis was also evaluated using mouse blood. For these experiments, ten Swiss mice were used, obtained from the Multidisciplinary Center for Biological Investigation of the State University of Campinas (CEMIB/ UNICAMP). All animals obtained from CEMIB received water and food ad libitum

Interface properties of nanostructured carbon-coated biological implants: an overview

• Mattia Bartoli,
• Francesca Cardano,
• Erik Piatti,
• Stefania Lettieri,
• Andrea Fin and
• Alberto Tagliaferro

Beilstein J. Nanotechnol. 2024, 15, 1041–1053, doi:10.3762/bjnano.15.85

• PVD for producing the coating, evaluating both hemolysis and blood coagulation to assess the antithrombotic properties of the graphene coating. The coated implant showed a higher hydrophobicity with less adhered platelets and a 70% reduction of hemolysis. As mentioned, the hydrophobicity and low

• both anticorrosion and antithrombotic elements. The authors used PVD for the deposition of a micrometer-thick coating on stainless steel, controlling morphology, roughness, and mechanical parameters. The coated surfaces showed a reduction of hemolysis of 40% and a corrosion resistance increment of 96

Nanomedicines against Chagas disease: a critical review

• Maria Jose Morilla,
• Kajal Ghosal and
• Eder Lilia Romero

Beilstein J. Nanotechnol. 2024, 15, 333–349, doi:10.3762/bjnano.15.30

• proteins, and prematurely release their cargos; also, they are phagocytosed by circulating monocytes or tissue macrophages to be degraded. This gives rise to the emergence of new modes of toxicity, including hemolysis, inflammation, oxidative stress, and impaired lysosomal or mitochondrial function. In the

Nanostructured lipid carriers containing benznidazole: physicochemical, biopharmaceutical and cellular in vitro studies

• Giuliana Muraca,
• María Esperanza Ruiz,
• Rocío C. Gambaro,
• Sebastián Scioli-Montoto,
• María Laura Sbaraglini,
• Gisel Padula,
• José Sebastián Cisneros,
• Cecilia Yamil Chain,
• Vera A. Álvarez,
• Cristián Huck-Iriart,
• Guillermo R. Castro,
• María Belén Piñero,
• Matias Ildebrando Marchetto,
• Catalina Alba Soto,
• Germán A. Islan and
• Alan Talevi

Beilstein J. Nanotechnol. 2023, 14, 804–818, doi:10.3762/bjnano.14.66

• incubation with the formulation of nanoparticles or the free drug. Hemolytic effect Hemolysis was assessed on 3 mL of a freshly drawn heparinized suspension of fresh human blood placed on a 6-well cell culture plate. Increasing concentrations of freshly prepared dilutions of the free drug and NLC-BNZ (1, 5

Polymer nanoparticles from low-energy nanoemulsions for biomedical applications

• Santiago Grijalvo and
• Carlos Rodriguez-Abreu

Beilstein J. Nanotechnol. 2023, 14, 339–350, doi:10.3762/bjnano.14.29

• and cell viabilities higher than 75% (for concentrations below 100 nM). These nanoparticles displayed high gene silencing efficiencies (up to 90%) targeting Renilla luciferase mRNA, particularly when coated with PEG (Figure 3) and did not show hemolysis after incubation with red blood cells. PLGA

• SH-SY5Y cells, and no hemolysis was observed. The presence of Tat on the surface of the nanoparticles enabled cell membrane penetration and uptake in HeLa Cells. The effect of electrolytes in the aqueous phase on Polysorbate 80-based PIC nanoemulsions and derived PLGA nanoparticles has been explored

Bacterial safety study of the production process of hemoglobin-based oxygen carriers

• Axel Steffen,
• Yu Xiong,
• Radostina Georgieva,
• Ulrich Kalus and
• Hans Bäumler

Beilstein J. Nanotechnol. 2022, 13, 114–126, doi:10.3762/bjnano.13.8

• Microbiology, Wesel, Germany. Hemoglobin was prepared by hypotonic hemolysis as described earlier [62][63] with slight adjustments. Briefly, fresh bovine whole blood (anticoagulated with 2 g/L of EDTA, provided by Biophyll GmbH, Dietersburg, Germany) was centrifuged for 20 min at 2500g at 2–8 °C. The resulting

Comprehensive review on ultrasound-responsive theranostic nanomaterials: mechanisms, structures and medical applications

• Sepand Tehrani Fateh,
• Lida Moradi,
• Elmira Kohan,
• Michael R. Hamblin and
• Amin Shiralizadeh Dezfuli

Beilstein J. Nanotechnol. 2021, 12, 808–862, doi:10.3762/bjnano.12.64

Doxorubicin-loaded gold nanorods: a multifunctional chemo-photothermal nanoplatform for cancer management

• Uzma Azeem Awan,
• Abida Raza,
• Shaukat Ali,
• Rida Fatima Saeed and
• Nosheen Akhtar

Beilstein J. Nanotechnol. 2021, 12, 295–303, doi:10.3762/bjnano.12.24

• remained higher than 88% at concentrations of 500 µg/mL for HepG2 cells and 1000 µg/mL for 3T3 cells (Figure 4a). If nanoparticles interact with red blood cells (RBCs) in the blood stream they can cause hemolysis. Hemolytic properties and interaction with RBCs are the main parameters for the

• biocompatibility of nanocarriers [23]. Analysis of hemoglobin released from RBCs after incubation in a suspension of PSS-GNRs showed less than 20% hemolysis at a concentration of 1000 μg/mL (Figure 4b). The experiments revealed a good biocompatibility of PSS-GNRs, which was quantified by the concentration of

• 10% FBS and 1% pen–strep. After 24 h of incubation, cells were exposed to different concentrations of PSS-coated GNRs and were allowed to incubate at 37 °C for additional 24 h. Viability was measured by the MTT assay [40]. Hemolysis assay All human blood samples in this study were from healthy

Facile biogenic fabrication of hydroxyapatite nanorods using cuttlefish bone and their bactericidal and biocompatibility study

• Satheeshkumar Balu,
• Manisha Vidyavathy Sundaradoss,
• Swetha Andra and
• Jaison Jeevanandam

Beilstein J. Nanotechnol. 2020, 11, 285–295, doi:10.3762/bjnano.11.21

• confirm the presence of nanorods and to evaluate their physicochemical properties. Furthermore, in vitro antimicrobial studies with gram-positive (Staphylococcus aureus) and gram-negative (Escherichia coli) bacteria, in addition to hemolysis studies with healthy human blood were performed to evaluate the

• and Materials standard F756-00. Generally, the addition of hydroxyapatite microcrystals with blood will lead to hemolysis via aggregation of erythrocytes and membrane damage induced by crystals [49]. Moreover, Wiessner et al. (1988) showed that the crystallinity of the Hap plays a crucial role in

• determining the hemolytic properties [50]. However, the CB-Hap NRs exhibited less than 2% hemolysis up to 75 µg/mL, which indicates that the material is nonhemolytic and nontoxic to blood cells. Additionally, 2% and 3.2% hemolytic activity was recorded when a higher concentration of CB-Hap NRs, such as 100

Phase inversion-based nanoemulsions of medium chain triglyceride as potential drug delivery system for parenteral applications

• Eike Folker Busmann,
• Dailén García Martínez,
• Henrike Lucas and
• Karsten Mäder

Beilstein J. Nanotechnol. 2020, 11, 213–224, doi:10.3762/bjnano.11.16

• products with significant hyperosmolality up to 2000 mOsmol/kg [13]. However, parenteral products should aim at isotonicity to reduce the risk of possible crenation (shriveling) or hemolysis of the red blood cells as well as significant pain at the site of injection or even phlebitis [13][14]. Therefore, a

Multiwalled carbon nanotube hybrids as MRI contrast agents

• Nikodem Kuźnik and
• Mateusz M. Tomczyk

Beilstein J. Nanotechnol. 2016, 7, 1086–1103, doi:10.3762/bjnano.7.102

• . Additionally, the Alamar Blue test was also used [32][37]. For administration by vein injection, hemolysis studies are also useful and give a general idea as to blood compatibility. Then, biodistribution and elimination sketch further the directions for the applications. An analysis of organs with an MRI

• period, is consistent with the abovementioned toxicity studies. Cytotoxicity and hemolysis Cytotoxicity of the nanohybrids was studied on various cell types (HeLa, HEK 293, human prostate cancer cells PC3, fibroblasts and others) and a general conclusion is the dose-dependent trend. However, the

Protein corona – from molecular adsorption to physiological complexity

• Lennart Treuel,
• Dominic Docter,
• Michael Maskos and
• Roland H. Stauber

Beilstein J. Nanotechnol. 2015, 6, 857–873, doi:10.3762/bjnano.6.88

• experiments by using primary human cell models of the blood system. Pristine NPs immediately affected the vitality of endothelial cells, triggered thrombocyte activation and aggregation, and resulted in hemolysis of erythrocytes. However, such pristine NPs existed only for a very brief period of time in the

Synthesis of boron nitride nanotubes and their applications

• Saban Kalay,
• Zehra Yilmaz,
• Ozlem Sen,
• Melis Emanet,
• Emine Kazanc and
• Mustafa Çulha

Beilstein J. Nanotechnol. 2015, 6, 84–102, doi:10.3762/bjnano.6.9

• normal MRC-5 fibroblast lung cells were investigated [76]. The hemolytic activity of the pure BNNTs was investigated by UV–vis spectroscopy and the results showed no significant hemolysis of cells that were exposed to the BNNTs. The metabolic activity of the BNNT-exposed cells using an MTT assay was